connect.lifescienceintegrates.com
About Us
For 15 years, Life Science Integrates (LSI) has brought together senior leaders from across the UK life sciences sector, creating a unique platform to identify industry challenges and shape strategic direction.
Our events and ecosystem have fostered the conversations, collaborations, and connections that helped create today’s landscape and that continue to set the agenda for the future.
We therefore launched LSI Connect, a business development consultancy designed to help international life science and Med-tech/Health-tech companies leverage our network, knowledge, and influence to empower organisations to accelerate growth, build trusted relationships, and expand effectively.
LSI Connect also collaborates with foreign Governments and Economic Development Agencies supporting market expansion programmes and investment attraction initiatives across multiple high-growth sectors.
Why LSI Connect?
What sets LSI Connect apart is our position at the centre of the UK life sciences ecosystem.
We don’t rely on cold outreach or surface-level networks — we operate through long-standing, trusted relationships that deliver real access. This gives our clients privileged insight, immediate credibility, and opportunities that typically take years to unlock.
By combining deep strategic market understanding with hands-on business development execution, LSI Connect enables international companies to enter, scale, and succeed in the UK with speed and confidence — and to expand seamlessly into key continental European markets through our established network and on-the-ground expertise.
The Team
Giulio Jossa
Managing Director
Giulio has a solid background in investment banking and has worked for over 10 years as an International Trade Consultant assisting clients ranging from scale-ups to Governments. Combining sharp market insight with hands-on commercial experience, Giulio bridges strategy and execution—delivering practical solutions that work in the real world.
Olivier Drapp
Scientific Advisor/BD
With over 30 years in Business Development at Pfizer, Olivier brings deep expertise in forging strategic partnerships across the life sciences. His work has included academic and biotech strategic alliances, open innovation collaborations, grant applications, and licensing (in and out) of manufacturing technologies aligned with net-zero goals.
Fabio D’Agostino
Scientific Advisor/BD
Fabio is a global consultant and biotech specialist with over 15 years’ experience in cell and gene therapy. He advises pharma companies, investors, and biotech startups on strategy, asset evaluation, and value creation, helping them build strong, investable propositions.
In 2019, Fabio joined Claris Ventures, an €85M biotech venture capital fund, supporting early-stage biopharma investments. He also contributes to the Parenteral Drug Association (PDA) Cell and Gene Task Force, collaborating with industry leaders to develop best practices, including PDA Technical Report 81 on manufacturing control strategies for cell and gene therapies.
Fabio holds a BSc and MSc in Biomedical Engineering from the Polytechnic University of Turin, as well as an Engineering Doctorate in Biopharmaceutical Process Development from Newcastle University (UK).
Robert Hull
Scientific Advisor/BD
Robert is a consultant with a background spanning industry, academia, and the NHS, specialising in the development and implementation of MedTech and life sciences technologies. He works with innovators, government agencies, the NHS, universities, and commercial organisations to support the successful adoption of innovative healthcare technologies in the UK. Robert provides companies with critical insight across data analysis, government policy alignment, regulatory requirements, and health economics to enable effective market access into the NHS. He also collaborates closely with the NHS and other public health providers to develop innovation strategies, design patient pathways, and support the adoption of new healthcare technologies. Robert holds a PhD in Microbiology and Industry from the University of Southampton.